Reply
Reply†
First published: 07 November 2008
No abstract is available for this article.
References
- 1
van de Beek D,
Weisfelt M,
de Gans J, et al.
Drug insight: adjunctive therapies in adults with bacterial meningitis.
Nat Clin Pract Neurol
2006;
2:
504–516.
- 2
van de Beek D,
de Gans J,
Tunkel AR,
Wijdicks EF.
Community-acquired bacterial meningitis in adults.
N Engl J Med
2006;
354:
44–53.
- 3
van de Beek D,
de Gans J,
Spanjaard L, et al.
Clinical features and prognostic factors in adults with bacterial meningitis.
N Engl J Med
2004;
351:
1849–1859.
- 4
Weisfelt M,
Determann RM,
de Gans, et al.
Procoagulant and fibrinolytic activity in cerebrospinal fluid from adults with bacterial meningitis.
J Infect
2007;
54:
545–550.
- 5
Weisfelt M,
van de Beek D,
Spanjaard L, et al.
A risk score for unfavorable outcome in adults with bacterial meningitis.
Ann Neurol
2008;
63:
90–97.
